Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar

Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar

Source: 
BioPharma Dive
snippet: 

Biotech startup Jaguar Gene Therapy has raised $139 million in new funding from high-profile backers Eli Lilly and ARCH Venture Partners, which joined venture founder Deerfield Management in closing a Series B round announced Tuesday.